Skip to content
Screener

LivaNova LIVN Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$390.6MBeat by $10.1M
EPS$1.26Beat by $0.17
Revenue estimate$380.5M
EPS estimate$1.09
“In the second quarter, LivaNova delivered strong revenue growth driven by sustained performance in our Cardiopulmonary and Epilepsy businesses. We are also pleased to announce an agreement with Thermo Fisher Scientific, an important step in securing a critical component for our oxygenators, supporting the Cardiopulmonary supply chain long-term. Our updated 2026 guidance reflects strong execution in the core businesses as we advance our strategic plan and drive long-term value creation.”
Vladimir Makatsaria

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$381.1M
EPS estimate$1.04

Financials

Q2 2026

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$4.38B+45.3%
Enterprise value$4.21B+45.0%
P/E23.7×—
P/S3×+0.7×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Segments

By segment

See full
Cardiopulmonary$221.6M+11.2%
Neuromodulation$166.9M+10.1%

By geography

See full
Rest of World$109.4M+12.5%
Europe$81.8M+22.5%

FAQ

When did LivaNova report Q2 2026 earnings?
LivaNova (LIVN) reported Q2 2026 earnings on August 5, 2026 before market open.
What were LivaNova's Q2 2026 revenue and EPS?
LivaNova reported revenue of $390.6M and eps of $1.26 for Q2 2026.
Did LivaNova beat estimates in Q2 2026?
Revenue beat the consensus estimate of $380.5M by $10.1M. EPS beat the consensus estimate of $1.09 by $0.17.
How did LivaNova's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.8% from $352.5M a year earlier and eps grew 20.0% from $1.05.
Where can I find LivaNova's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001639691-26-000085) and the 10-Q periodic report (0001639691-26-000090) directly on SEC EDGAR. The filing index links above go to sec.gov.